Oil & Gas Exploration & Production
Compare Stocks
5 / 10Stock Comparison
VIVK vs XOM vs SLB vs HAL vs CVX
Revenue, margins, valuation, and 5-year total return — side by side.
Oil & Gas Integrated
Oil & Gas Equipment & Services
Oil & Gas Equipment & Services
Oil & Gas Integrated
VIVK vs XOM vs SLB vs HAL vs CVX — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Oil & Gas Exploration & Production | Oil & Gas Integrated | Oil & Gas Equipment & Services | Oil & Gas Equipment & Services | Oil & Gas Integrated |
| Market Cap | $2K | $611.92B | $79.97B | $33.26B | $362.06B |
| Revenue (TTM) | $104M | $323.90B | $35.71B | $22.17B | $184.43B |
| Net Income (TTM) | $-110M | $28.84B | $3.35B | $1.54B | $12.30B |
| Gross Margin | 21.1% | 21.7% | 18.2% | 15.3% | 30.4% |
| Operating Margin | -22.3% | 10.5% | 15.3% | 11.3% | 9.0% |
| Forward P/E | 63.1x | 14.3x | 20.3x | 17.1x | 14.7x |
| Total Debt | $35M | $43.54B | $12.31B | $8.13B | $46.74B |
| Cash & Equiv. | $265K | $10.68B | $3.04B | $2.21B | $6.47B |
VIVK vs XOM vs SLB vs HAL vs CVX — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Vivakor, Inc. (VIVK) | 100 | 0.0 | -100.0% |
| Exxon Mobil Corpora… (XOM) | 100 | 317.6 | +217.6% |
| SLB N.V. (SLB) | 100 | 288.4 | +188.4% |
| Halliburton Company (HAL) | 100 | 339.0 | +239.0% |
| Chevron Corporation (CVX) | 100 | 197.9 | +97.9% |
Price return only. Dividends and distributions are not included.
Quick Verdict: VIVK vs XOM vs SLB vs HAL vs CVX
Each card shows where this stock fits in a portfolio — not just who wins on paper.
VIVK has the current edge in this matchup, primarily because of its strength in income & stability.
- Dividend streak 0 yrs, beta 0.68, yield 100.0%
- 16.3% revenue growth vs CVX's -4.6%
- 100.0% yield, vs XOM's 2.8%
XOM is the clearest fit if your priority is value.
- Lower P/E (14.3x vs 14.7x)
SLB is the #2 pick in this set and the best alternative if growth exposure is your priority.
- Rev growth -1.6%, EPS growth -24.4%, 3Y rev CAGR 8.3%
- 9.4% margin vs VIVK's -105.6%
- 6.5% ROA vs VIVK's -57.5%, ROIC 12.1% vs -13.1%
HAL ranks third and is worth considering specifically for sleep-well-at-night and defensive.
- Lower volatility, beta 0.48, Low D/E 77.4%, current ratio 2.04x
- Beta 0.48, yield 1.7%, current ratio 2.04x
- Beta 0.48 vs SLB's 0.83
- +100.1% vs VIVK's -100.0%
CVX is the clearest fit if your priority is long-term compounding.
- 134.7% 10Y total return vs XOM's 102.6%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 16.3% revenue growth vs CVX's -4.6% | |
| Value | Lower P/E (14.3x vs 14.7x) | |
| Quality / Margins | 9.4% margin vs VIVK's -105.6% | |
| Stability / Safety | Beta 0.48 vs SLB's 0.83 | |
| Dividends | 100.0% yield, vs XOM's 2.8% | |
| Momentum (1Y) | +100.1% vs VIVK's -100.0% | |
| Efficiency (ROA) | 6.5% ROA vs VIVK's -57.5%, ROIC 12.1% vs -13.1% |
VIVK vs XOM vs SLB vs HAL vs CVX — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
VIVK vs XOM vs SLB vs HAL vs CVX — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
SLB leads in 1 of 6 categories
VIVK leads 1 • XOM leads 1 • HAL leads 0 • CVX leads 0 • 3 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
SLB leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
XOM is the larger business by revenue, generating $323.9B annually — 3102.0x VIVK's $104M. SLB is the more profitable business, keeping 9.4% of every revenue dollar as net income compared to VIVK's -105.6%. On growth, SLB holds the edge at +5.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $104M | $323.9B | $35.7B | $22.2B | $184.4B |
| EBITDAEarnings before interest/tax | -$5M | $59.9B | $7.4B | $3.4B | $37.1B |
| Net IncomeAfter-tax profit | -$110M | $28.8B | $3.4B | $1.5B | $12.3B |
| Free Cash FlowCash after capex | -$16M | $23.6B | $4.8B | $1.7B | $16.2B |
| Gross MarginGross profit ÷ Revenue | +21.1% | +21.7% | +18.2% | +15.3% | +30.4% |
| Operating MarginEBIT ÷ Revenue | -22.3% | +10.5% | +15.3% | +11.3% | +9.0% |
| Net MarginNet income ÷ Revenue | -105.6% | +8.9% | +9.4% | +6.9% | +6.7% |
| FCF MarginFCF ÷ Revenue | -15.1% | +7.3% | +13.4% | +7.6% | +8.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | -49.6% | -1.3% | +5.0% | -0.3% | -5.3% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.9% | -11.0% | -31.2% | +129.2% | -24.5% |
Valuation Metrics
VIVK leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 21.6x trailing earnings, XOM trades at a 21% valuation discount to CVX's 27.4x P/E. On an enterprise value basis, XOM's 10.8x EV/EBITDA is more attractive than SLB's 12.1x.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $2,240 | $611.9B | $80.0B | $33.3B | $362.1B |
| Enterprise ValueMkt cap + debt − cash | $35M | $644.8B | $89.2B | $39.2B | $402.3B |
| Trailing P/EPrice ÷ TTM EPS | 0.00x | 21.55x | 22.67x | 26.55x | 27.37x |
| Forward P/EPrice ÷ next-FY EPS est. | 63.10x | 14.31x | 20.26x | 17.13x | 14.68x |
| PEG RatioP/E ÷ EPS growth rate | — | — | — | — | — |
| EV / EBITDAEnterprise value multiple | — | 10.76x | 12.11x | 11.54x | 10.84x |
| Price / SalesMarket cap ÷ Revenue | 0.00x | 1.89x | 2.24x | 1.50x | 1.96x |
| Price / BookPrice ÷ Book value/share | 0.00x | 2.33x | 2.90x | 3.18x | 1.75x |
| Price / FCFMarket cap ÷ FCF | — | 25.92x | 16.68x | 19.89x | 21.82x |
Profitability & Efficiency
Evenly matched — VIVK and SLB each lead in 3 of 9 comparable metrics.
Profitability & Efficiency
HAL delivers a 14.6% return on equity — every $100 of shareholder capital generates $15 in annual profit, vs $-143 for VIVK. XOM carries lower financial leverage with a 0.16x debt-to-equity ratio, signaling a more conservative balance sheet compared to VIVK's 0.95x. On the Piotroski fundamental quality scale (0–9), VIVK scores 5/9 vs XOM's 3/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -143.1% | +10.7% | +13.9% | +14.6% | +7.2% |
| ROA (TTM)Return on assets | -57.5% | +6.4% | +6.5% | +6.1% | +4.2% |
| ROICReturn on invested capital | -13.1% | +8.6% | +12.1% | +10.2% | +6.2% |
| ROCEReturn on capital employed | -25.9% | +8.9% | +14.3% | +11.6% | +6.6% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 3 | 4 | 5 | 5 |
| Debt / EquityFinancial leverage | 0.95x | 0.16x | 0.45x | 0.77x | 0.24x |
| Net DebtTotal debt minus cash | $35M | $32.9B | $9.3B | $5.9B | $40.3B |
| Cash & Equiv.Liquid assets | $265,019 | $10.7B | $3.0B | $2.2B | $6.5B |
| Total DebtShort + long-term debt | $35M | $43.5B | $12.3B | $8.1B | $46.7B |
| Interest CoverageEBIT ÷ Interest expense | -3.06x | 69.44x | 9.40x | 9.19x | 17.22x |
Total Returns (Dividends Reinvested)
XOM leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in XOM five years ago would be worth $26,064 today (with dividends reinvested), compared to $0 for VIVK. Over the past 12 months, HAL leads with a +100.1% total return vs VIVK's -100.0%. The 3-year compound annual growth rate (CAGR) favors XOM at 12.7% vs VIVK's -96.6% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | -99.5% | +18.6% | +33.2% | +35.1% | +17.5% |
| 1-Year ReturnPast 12 months | -100.0% | +39.9% | +58.6% | +100.1% | +37.4% |
| 3-Year ReturnCumulative with dividends | -100.0% | +43.0% | +21.3% | +39.7% | +26.0% |
| 5-Year ReturnCumulative with dividends | -100.0% | +160.6% | +82.8% | +87.4% | +93.8% |
| 10-Year ReturnCumulative with dividends | -100.0% | +102.6% | -8.9% | +18.1% | +134.7% |
| CAGR (3Y)Annualised 3-year return | -96.6% | +12.7% | +6.7% | +11.8% | +8.0% |
Risk & Volatility
Evenly matched — XOM and HAL each lead in 1 of 2 comparable metrics.
Risk & Volatility
XOM is the less volatile stock with a -0.20 beta — it tends to amplify market swings less than SLB's 0.83 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. HAL currently trades 93.8% from its 52-week high vs VIVK's 0.0% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.68x | -0.20x | 0.83x | 0.48x | -0.11x |
| 52-Week HighHighest price in past year | $52000.00 | $176.41 | $57.20 | $42.46 | $214.71 |
| 52-Week LowLowest price in past year | $0.01 | $101.19 | $31.64 | $19.38 | $133.77 |
| % of 52W HighCurrent price vs 52-week peak | +0.0% | +81.8% | +93.1% | +93.8% | +84.5% |
| RSI (14)Momentum oscillator 0–100 | 30.2 | 39.5 | 47.7 | 48.6 | 39.2 |
| Avg Volume (50D)Average daily shares traded | 51K | 18.9M | 16.2M | 14.9M | 11.0M |
Analyst Outlook
Evenly matched — VIVK and XOM each lead in 1 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: XOM as "Hold", SLB as "Buy", HAL as "Buy", CVX as "Buy". Consensus price targets imply 11.6% upside for XOM (target: $161) vs -0.5% for HAL (target: $40). For income investors, VIVK offers the higher dividend yield at 100.00% vs HAL's 1.73%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | — | Hold | Buy | Buy | Buy |
| Price TargetConsensus 12-month target | — | $161.08 | $58.66 | $39.64 | $194.87 |
| # AnalystsCovering analysts | — | 55 | 66 | 64 | 53 |
| Dividend YieldAnnual dividend ÷ price | +100.0% | +2.8% | +2.0% | +1.7% | +3.8% |
| Dividend StreakConsecutive years of raises | 0 | 26 | 4 | 4 | 8 |
| Dividend / ShareAnnual DPS | $2805.43 | $4.00 | $1.08 | $0.69 | $6.87 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +3.3% | +3.0% | +3.0% | +3.3% |
SLB leads in 1 of 6 categories (Income & Cash Flow). VIVK leads in 1 (Valuation Metrics). 3 tied.
VIVK vs XOM vs SLB vs HAL vs CVX: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is VIVK or XOM or SLB or HAL or CVX a better buy right now?
For growth investors, Vivakor, Inc.
(VIVK) is the stronger pick with 16. 3% revenue growth year-over-year, versus -4. 6% for Chevron Corporation (CVX). Exxon Mobil Corporation (XOM) offers the better valuation at 21. 6x trailing P/E (14. 3x forward), making it the more compelling value choice. Analysts rate SLB N. V. (SLB) a "Buy" — based on 66 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — VIVK or XOM or SLB or HAL or CVX?
On trailing P/E, Exxon Mobil Corporation (XOM) is the cheapest at 21.
6x versus Chevron Corporation at 27. 4x. On forward P/E, Exxon Mobil Corporation is actually cheaper at 14. 3x.
03Which is the better long-term investment — VIVK or XOM or SLB or HAL or CVX?
Over the past 5 years, Exxon Mobil Corporation (XOM) delivered a total return of +160.
6%, compared to -100. 0% for Vivakor, Inc. (VIVK). Over 10 years, the gap is even starker: CVX returned +134. 7% versus VIVK's -100. 0%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — VIVK or XOM or SLB or HAL or CVX?
By beta (market sensitivity over 5 years), Exxon Mobil Corporation (XOM) is the lower-risk stock at -0.
20β versus SLB N. V. 's 0. 83β — meaning SLB is approximately -524% more volatile than XOM relative to the S&P 500. On balance sheet safety, Exxon Mobil Corporation (XOM) carries a lower debt/equity ratio of 16% versus 95% for Vivakor, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — VIVK or XOM or SLB or HAL or CVX?
By revenue growth (latest reported year), Vivakor, Inc.
(VIVK) is pulling ahead at 16. 3% versus -4. 6% for Chevron Corporation (CVX). On earnings-per-share growth, the picture is similar: Exxon Mobil Corporation grew EPS -14. 5% year-over-year, compared to -109. 2% for Vivakor, Inc.. Over a 3-year CAGR, VIVK leads at 54. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — VIVK or XOM or SLB or HAL or CVX?
SLB N.
V. (SLB) is the more profitable company, earning 9. 4% net margin versus -105. 6% for Vivakor, Inc. — meaning it keeps 9. 4% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: SLB leads at 15. 3% versus -22. 3% for VIVK. At the gross margin level — before operating expenses — VIVK leads at 36. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is VIVK or XOM or SLB or HAL or CVX more undervalued right now?
On forward earnings alone, Exxon Mobil Corporation (XOM) trades at 14.
3x forward P/E versus 63. 1x for Vivakor, Inc. — 48. 8x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for XOM: 11. 6% to $161. 08.
08Which pays a better dividend — VIVK or XOM or SLB or HAL or CVX?
All stocks in this comparison pay dividends.
Vivakor, Inc. (VIVK) offers the highest yield at 100. 0%, versus 1. 7% for Halliburton Company (HAL).
09Is VIVK or XOM or SLB or HAL or CVX better for a retirement portfolio?
For long-horizon retirement investors, Exxon Mobil Corporation (XOM) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
20), 2. 8% yield, +102. 6% 10Y return). Both have compounded well over 10 years (XOM: +102. 6%, SLB: -8. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between VIVK and XOM and SLB and HAL and CVX?
Both stocks operate in the Energy sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: VIVK is a small-cap high-growth stock; XOM is a large-cap quality compounder stock; SLB is a mid-cap quality compounder stock; HAL is a mid-cap quality compounder stock; CVX is a large-cap income-oriented stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.